Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing
Reexamination Certificate
2011-07-19
2011-07-19
Carlson, Karen Cochrane (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C530S350000
Reexamination Certificate
active
07981857
ABSTRACT:
The invention relates to Cerberus/Dan/Gremlin polypeptides or variants thereof for use in treating a variety of disorders associated with myostatin, nodal and GDF-11. Preferred polypeptides are Coco or Cerberus derivatives.
REFERENCES:
patent: 5935852 (1999-08-01), Follettie et al.
patent: 6133232 (2000-10-01), De Robertis et al.
patent: 6610510 (2003-08-01), Valenzuela et al.
patent: 2002/0164682 (2002-11-01), Follettie et al.
patent: 2002/0194704 (2002-12-01), Snowden et al.
patent: 2003/0134790 (2003-07-01), Langenfeld
patent: 2003/0194704 (2003-10-01), Penn et al.
patent: 2003/0199042 (2003-10-01), Valenzuela et al.
patent: 2004/0005560 (2004-01-01), Isogai et al.
patent: 2004/0181033 (2004-09-01), Han et al.
patent: 2005/0186663 (2005-08-01), Davies et al.
patent: 2006/0105376 (2006-05-01), Isogai et al.
patent: 1347046 (2003-09-01), None
patent: WO-97/48275 (1997-12-01), None
patent: WO-98/34951 (1998-08-01), None
patent: WO-98/49296 (1998-11-01), None
patent: WO-99/01553 (1999-01-01), None
patent: WO-99/40181 (1999-08-01), None
patent: WO-00/55193 (2000-09-01), None
patent: WO-02/10214 (2002-02-01), None
patent: WO-02/32929 (2002-04-01), None
patent: WO-02/054940 (2002-07-01), None
patent: WO-02/077204 (2002-10-01), None
patent: WO-02/078516 (2002-10-01), None
patent: WO-02/090992 (2002-11-01), None
patent: WO-03/005543 (2003-01-01), None
patent: WO-03/012082 (2003-02-01), None
patent: WO-03/055443 (2003-07-01), None
patent: WO 03/055443 (2003-07-01), None
patent: WO-03/055911 (2003-07-01), None
patent: WO-03/072714 (2003-09-01), None
patent: WO-03/106654 (2003-12-01), None
patent: WO-03/106657 (2003-12-01), None
patent: WO-2004/074460 (2004-09-01), None
patent: WO-2005/003158 (2005-01-01), None
Avsian-Kretchmer et al., “Comparative geneomic analysisof the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists,” Molecular Endocrinology 18(1):1-12 (2004).
Belo et al., “Cerberus-likeis a secreted factor with nerualizing activity expressed in the anterior primitive endoderm of the mouse gastrula,” Mechanisims of Development 68:45-57 (1997).
Biben et al., “Murine Cerberus Homologue mCer-1: A canadidate anterior patterning molecule,” Developmental Biology 194:135-151 (1998).
Bouwmeester et al., “Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer,” Nature 382:595-601 (1996).
Esteban et al., “The novel Cer-like protein Caronte mediates the extablishment of embryonic left-right asymmetry,” Nature 401:243-251 (1999).
Katoh et al., “Identification and characterization of humanCKTSF1B2andCKTSF1B3genes in silico,” Oncology Reports 12:423-427 (2004).
Kuroda et al., “Neural Induction inXenopus: requirement for extodermal and endomesodermal signals via chordin, noggin, β-catenin and cerberus,” PLoS Biology 2(5):0623-0634 (2004).
Lah et al., “Humancerberusrelated geneCER1maps to chromosome 9,” Genomics 55:364-366 (1999).
Marques et al., “The activity of the nodal antagonistCerl-2in the mouse node is required for correct L/R body axis,” Genes & Development 18:2342-2347 (2004).
Pearce et al., “A mouse cerberus/dan-related gene family,” Developmental Biology 209:98-110 (1999).
Piccolo et al., “The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals,” Nature 397:707-710 (1999).
Silva et al., “Endogenous Cerberus activity is required for anterior head specification inXenopus,” Development 130(20):4943-4953 (2003).
Stanley et al., “MurinecerberushomologueCer1maps to chromosome 4,” Genomics 49:337-338 (1998).
Yanagita, M., “BMP antagonists: Their roles in development and involvement in pathophysiology,” Cytokine and Growth Factor Reviews, 16(3):309-317 (2005).
Knopf John
Seehra Jasbir
Acceleron Pharma Inc.
Carlson Karen Cochrane
Ropes & Gray LLP
LandOfFree
Cerberus/coco derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cerberus/coco derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cerberus/coco derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2714524